Cengild Medical Berhad Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Wai Lee

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	n/a
Yönetim ortalama görev süresi	2.3yrs
Yönetim Kurulu ortalama görev süresi	3.5yrs

Son yönetim güncellemeleri

Recent updates

Cengild Medical Berhad's (KLSE:CENGILD) Weak Earnings May Only Reveal A Part Of The Whole Picture

Jun 04

Cengild Medical Berhad (KLSE:CENGILD) Might Have The Makings Of A Multi-Bagger

Apr 05

Investors Can Find Comfort In Cengild Medical Berhad's (KLSE:CENGILD) Earnings Quality

Sep 01

A Look At The Fair Value Of Cengild Medical Berhad (KLSE:CENGILD)

Aug 31

CEO

Wai Lee (49 yo)

no data

Görev süresi

Ms. Wai Fern Lee is Group Chief Executive Officer of Cengild Medical Berhad from November 1, 2024. Ms. Lee served as Chief Financial Officer at SMRT Holdings Berhad since November 2014 until December 18, 2...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Huck Tan	Executive Chairman & Medical Director	3.8yrs	RM 5.44m	16.18% MYR 36.4m
Mohamed Bin Mohamed Ditali Qureshi	Head of Medical Adv. Board and Operating Theatre & Central Sterile Supply Dept. and Exec. Director	no data	RM 1.98m	6.76% MYR 15.2m
Wai Lee	Group Chief Executive Officer	no data	Veri yok	Veri yok
Yoon Lian	Financial Controller	less than a year	Veri yok	Veri yok
Siew Ong	Head of Department	3.5yrs	Veri yok	3.87% MYR 8.7m
Ramesh Gurunathan	Head of Inpatient Department	3.5yrs	Veri yok	4.72% MYR 10.6m
Mustafa Taher	Head of Outpatient Department	3.5yrs	Veri yok	Veri yok
Thiam Tee	Company Secretary	1.2yrs	Veri yok	Veri yok
Siew Wong	Company Secretary	1.2yrs	Veri yok	Veri yok

2.3yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim: CENGILD 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.3 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Huck Tan	Executive Chairman & Medical Director	3.8yrs	RM 5.44m	16.18% MYR 36.4m
Mohamed Bin Mohamed Ditali Qureshi	Head of Medical Adv. Board and Operating Theatre & Central Sterile Supply Dept. and Exec. Director	3.5yrs	RM 1.98m	6.76% MYR 15.2m
Choo Kua	Independent Non-Executive Director	3.5yrs	RM 51.00k	Veri yok
Su-Lin Chong	Independent Non-Executive Director	3.5yrs	RM 51.00k	Veri yok
Azrina Binti Abu Bakar	Independent Non-Executive Director	3.5yrs	RM 51.00k	0.024% MYR 54.0k

3.5yrs

Ortalama Görev Süresi

63yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: CENGILD 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.5 yıldır).

Cengild Medical Berhad Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Cengild Medical Berhad Announces the Retirement of Yap Soh Kim as Acting Chief Executive Officer

Cengild Medical Berhad, Annual General Meeting, Nov 29, 2024

Cengild Medical Berhad Announces Appointment of John Lian Yoon Ahn as Principal Officer

Cengild Medical Berhad, Annual General Meeting, May 13, 2024

Cengild Medical Berhad Appoints Miss Yap Soh Kim as the Acting Chief Executive Officer

Cengild Medical Berhad Announces Retirement of Yap Soh Kim as Chief Executive Officer

Recent updates

Cengild Medical Berhad Announces the Retirement of Yap Soh Kim as Acting Chief Executive Officer

Cengild Medical Berhad, Annual General Meeting, Nov 29, 2024

Cengild Medical Berhad Announces Appointment of John Lian Yoon Ahn as Principal Officer

Full year 2024 earnings released: EPS: RM0.013 (vs RM0.016 in FY 2023)

Final dividend of RM0.0037 announced

Cengild Medical Berhad Declares Single Tier Interim Dividend in Respect of the Financial Year Ended 30 June 2024, Payable on 27 September 2024

Cengild Medical Berhad's (KLSE:CENGILD) Weak Earnings May Only Reveal A Part Of The Whole Picture

Third quarter 2024 earnings released: EPS: RM0.004 (vs RM0.004 in 3Q 2023)

Cengild Medical Berhad, Annual General Meeting, May 13, 2024

Cengild Medical Berhad Appoints Miss Yap Soh Kim as the Acting Chief Executive Officer

Cengild Medical Berhad (KLSE:CENGILD) Might Have The Makings Of A Multi-Bagger

Second quarter 2024 earnings released: EPS: RM0.004 (vs RM0.005 in 2Q 2023)

Cengild Declares Single Tier Interim Dividend for the Financial Year Ending 30 June 2024, Payable on 29 March 2024

First quarter 2024 earnings released: EPS: RM0.004 (vs RM0.004 in 1Q 2023)

Cengild Medical Berhad Announces Retirement of Yap Soh Kim as Chief Executive Officer

Cengild Medical Berhad, Annual General Meeting, Nov 29, 2023

Cengild Medical Berhad Announces Appointment of Tee Thiam Chai as Company Secretary

Full year 2023 earnings released: EPS: RM0.016 (vs RM0.015 in FY 2022)

Cengild Medical Berhad Declares Single Tier Interim Dividend in Respect of the Financial Year Ended 30 June 2023, Will Be Paid on 25 September 2023

Cengild Medical Berhad Appoints MICHEAL BONG ENN CHUNG @ MICHEAL WONG ENN CHUNG as Chief Executive Officer, Effective 01 July 2023

High number of new and inexperienced directors

Cengild Medical Berhad Announces Demise of Goh Khean Lee as Executive Director

Third quarter 2023 earnings released: EPS: RM0.004 (vs RM0.003 in 3Q 2022)

Second quarter 2023 earnings released: EPS: RM0.005 (vs RM0.004 in 2Q 2022)

First quarter 2023 earnings released: EPS: RM0.004 (vs RM0.002 in 1Q 2022)

Cengild Medical Berhad, Annual General Meeting, Nov 30, 2022

Investors Can Find Comfort In Cengild Medical Berhad's (KLSE:CENGILD) Earnings Quality

A Look At The Fair Value Of Cengild Medical Berhad (KLSE:CENGILD)

Cengild Medical Berhad Declares Single Tier Interim Dividend for the Financial Year Ended 30 June 2022, Payable on 27 September 2022

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş